PD-L1 Recruits Phospholipase C and Enhances EGFR Signaling: Relevance to Resistance of EGFR-Mutated Lung Tumors to Immunotherapy

MLA

Michal Lotem, et al. “PD-L1 Recruits Phospholipase C and Enhances EGFR Signaling: Relevance to Resistance of EGFR-Mutated Lung Tumors to Immunotherapy.” SSRN Electronic Journal, Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........24e412d36a3883d66efc870c0685b489&authtype=sso&custid=ns315887.

APA

Michal Lotem, Moshe Oren, Soma Ghosh, Sabina Winograd Katz, Arkaprabha Basu, Galit Eisenberg, Yan Lender, Saptaparna Mukherjee, Nishanth Belugali Nataraj, Eytan Ruppin, Sushant Patkar, Benjamin Geiger, Arunachalam Sekar, Yosef Yarden, Hava Gil-Henn, Shimon Weiss Daniel Neuhauser, Joseph Green, Ashish Noronha, Moshit Lindzen, & Diana Drago Garcia. (2020). PD-L1 Recruits Phospholipase C and Enhances EGFR Signaling: Relevance to Resistance of EGFR-Mutated Lung Tumors to Immunotherapy. SSRN Electronic Journal.

Chicago

Michal Lotem, Moshe Oren, Soma Ghosh, Sabina Winograd Katz, Arkaprabha Basu, Galit Eisenberg, Yan Lender, et al. 2020. “PD-L1 Recruits Phospholipase C and Enhances EGFR Signaling: Relevance to Resistance of EGFR-Mutated Lung Tumors to Immunotherapy.” SSRN Electronic Journal, January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........24e412d36a3883d66efc870c0685b489&authtype=sso&custid=ns315887.